The American College of Radiology (ACR) is sounding the alarm that some commercial payers may be requiring copayments for U.S. Preventive Services Task Force (USPSTF)-recommended preventive services, such as lung cancer screening with low-dose CT (LDCT).
"Lung Cancer Screening programs [have] alerted ACR that some payers are notifying imaging centers during prior authorization that cost sharing will apply for screening for lung cancer with low-dose computed tomography (LDCT)," the college said in a statement. "The payer action may be related to a recent Texas federal court ruling that invalidated the Affordable Care Act (ACA) requirement that USPSTF-approved preventive services be covered at no cost to the patient. However, the ruling has been appealed and it is not in effect; the College previously reported that it will continue to monitor this court ruling."
